Sign In
Buy BIIB
$207.94
+1.66 (+0.80%)
At Close: Aug 07, 2026
The New England Journal of Medicine Publishes First Data to Demonstrate the Potential for Disease Modification in Dravet Syndrome
05:05pm, Wednesday, 04'th Mar 2026
–Results show that targeting the underlying cause of Dravet syndrome with zorevunersen may improve outcomes for people with this rare, devastating genetic neurodevelopmental disease–
Biogen Inc. $BIIB Shares Sold by Fisher Asset Management LLC
04:22am, Wednesday, 04'th Mar 2026
Fisher Asset Management LLC reduced its stake in Biogen Inc. (NASDAQ: BIIB) by 4.1% in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commis
Biogen Inc. (BIIB) Presents at TD Cowen 46th Annual Health Care Conference Transcript
11:27am, Monday, 02'nd Mar 2026
Biogen Inc. (BIIB) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Biogen Inc. (NASDAQ:BIIB) Given Average Rating of “Hold” by Brokerages
01:58am, Friday, 27'th Feb 2026
Shares of Biogen Inc. (NASDAQ: BIIB - Get Free Report) have earned an average recommendation of "Hold" from the twenty-seven brokerages that are covering the stock, MarketBeat Ratings reports. Fifteen
Here's Why Biogen Inc. (BIIB) is a Strong Momentum Stock
10:50am, Monday, 23'rd Feb 2026
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
China Universal Asset Management Co. Ltd. Has $4.14 Million Holdings in Biogen Inc. $BIIB
06:36am, Friday, 20'th Feb 2026
China Universal Asset Management Co. Ltd. lessened its holdings in Biogen Inc. (NASDAQ: BIIB) by 9.7% in the third quarter, according to the company in its most recent 13F filing with the Securities a
Why Biogen Inc. (BIIB) is a Top Value Stock for the Long-Term
10:41am, Thursday, 19'th Feb 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
AlphaQuest LLC Sells 10,789 Shares of Biogen Inc. $BIIB
03:23am, Monday, 16'th Feb 2026
AlphaQuest LLC decreased its position in shares of Biogen Inc. (NASDAQ: BIIB) by 96.6% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commissio
Biogen Inc. (BIIB) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
01:07pm, Friday, 13'th Feb 2026
Biogen Inc. (BIIB) Presents at Piper Sandler Virtual Novel Targets in Immunology Symposium Transcript
Biogen Announces Board Chair Transition
05:00pm, Wednesday, 11'th Feb 2026
Caroline Dorsa to retire from the Biogen Board of Directors; Dr. Maria C. Freire, Director since 2021, elected as new Chair Caroline Dorsa to retire from the Biogen Board of Directors; Dr. Maria C. Fr
Candriam S.C.A. Decreases Holdings in Biogen Inc. $BIIB
05:24am, Tuesday, 10'th Feb 2026
Candriam S.C.A. lowered its stake in Biogen Inc. (NASDAQ: BIIB) by 2.8% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. Th
State of Michigan Retirement System Has $6.04 Million Position in Biogen Inc. $BIIB
03:56am, Tuesday, 10'th Feb 2026
State of Michigan Retirement System cut its stake in Biogen Inc. (NASDAQ: BIIB) by 85.2% during the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Com
Biogen Analysts Boost Their Forecasts After Upbeat Q4 Earnings
08:36am, Monday, 09'th Feb 2026
Biogen Inc. (NASDAQ: BIIB) on Friday reported better-than-expected fourth-quarter earnings.
Biogen FY25 Earnings: Stable EPS, Amid Pressure From The Multiple Sclerosis Franchise
06:49am, Monday, 09'th Feb 2026
Biogen (BIIB) is transitioning from a shrinking MS franchise to a portfolio anchored in rare disease and Alzheimer's therapies, driving improved mix quality. BIIB's 2025 growth products generated $3.3
Why Biogen Stock Surged Almost 9% Higher on Friday
07:47pm, Friday, 06'th Feb 2026
The biotech published its last set of financials for 2025. Its quarterly revenue and adjusted profitability declined, yet both still topped the consensus analyst estimates.
